Ludovic Helfgott
Since January 2017, Ludovic Helfgott has been the Global Vice-President of AstraZeneca’s cardiovascular, metabolism and renal franchise. Health economist by background, he joined AstraZeneca in 2005 and successively occupied several commercial leadership positions, alternating global and country senior roles, lately in Italy and in Spain. Up to recently, he was heading AstraZeneca’s global antiplatelet franchise.
Ludovic Helfgott holds a MA in Political Science and Economy from the Institut d’Etudes Politiques of Paris (France), a MA in Finance from ESSEC (France) and a MBA from INSEAD.